English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/171482
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorMárquez-Jurado, Silvia-
dc.contributor.authorNogales, Aitor-
dc.contributor.authorÁvila-Pérez, Ginés-
dc.contributor.authorIborra, Francisco J.-
dc.contributor.authorMartínez-Sobrido, Luis-
dc.contributor.authorAlmazán, Fernando-
dc.identifier.citationViruses 10(10): 547 (2018)-
dc.description.abstractThe recent outbreaks of Zika virus (ZIKV), its association with Guillain–Barré syndrome and fetal abnormalities, and the lack of approved vaccines and antivirals, highlight the importance of developing countermeasures to combat ZIKV disease. In this respect, infectious clones constitute excellent tools to accomplish these goals. However, flavivirus infectious clones are often difficult to work with due to the toxicity of some flavivirus sequences in bacteria. To bypass this problem, several alternative approaches have been applied for the generation of ZIKV clones including, among others, in vitro ligation, insertions of introns and using infectious subgenomic amplicons. Here, we report a simple and novel DNA-launched approach based on the use of a bacterial artificial chromosome (BAC) to generate a cDNA clone of Rio Grande do Norte Natal ZIKV strain. The sequence was identified from the brain tissue of an aborted fetus with microcephaly. The BAC clone was fully stable in bacteria and the infectious virus was efficiently recovered in Vero cells through direct delivery of the cDNA clone. The rescued virus yielded high titers in Vero cells and was pathogenic in a validated mouse model (A129 mice) of ZIKV infection. Furthermore, using this infectious clone we have generated a mutant ZIKV containing a single amino acid substitution (A175V) in the NS2A protein that presented reduced viral RNA synthesis in cell cultures, was highly attenuated in vivo and induced fully protection against a lethal challenge with ZIKV wild-type. This BAC approach provides a stable and reliable reverse genetic system for ZIKV that will help to identify viral determinants of virulence and facilitate the development of vaccine and therapeutic strategies.-
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) (grant number BFU2016-79127-R) to F.A. and F.J.I. and the National Institute of Health (NIH) (grant number 1R21AI120500) to L.M.-S. and F.A.-
dc.publisherMultidisciplinary Digital Publishing Institute-
dc.relation.isversionofPublisher's version-
dc.subjectZika virus-
dc.subjectFull-length cDNA infectious clones-
dc.subjectBacterial artificial chromosome-
dc.subjectNS2A protein-
dc.titleAn Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo-
dc.description.peerreviewedPeer reviewed-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderNational Institutes of Health (US)-
Appears in Collections:(CNB) Artículos
Files in This Item:
File Description SizeFormat 
viruses-10-00547-v2.pdf10,26 MBAdobe PDFThumbnail
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.